CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-16 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise | +774 | 8,892 | ||
| 2023-03-16 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −221 | $11.46 | $3K | 8,671 |
| 2023-03-16 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit | −774 | 1,549 | ||
| 2023-03-16 | Patel Sanj K CHAIRMAN & CEO | Option exercise | +6,569 | 28,965 | ||
| 2023-03-16 | Patel Sanj K CHAIRMAN & CEO | Shares withheld for taxes | −1,929 | $11.46 | $22K | 27,036 |
| 2023-03-16 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −6,569 | 13,138 | ||
| 2023-03-16 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise | +1,964 | 116,612 | ||
| 2023-03-16 | Tessari Eben CHIEF OPERATING OFFICER | Shares withheld for taxes | −577 | $11.46 | $7K | 116,035 |
| 2023-03-16 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit | −1,964 | 3,928 | ||
| 2023-03-16 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise | +872 | 8,543 | ||
| 2023-03-16 | Ragosa Mark CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −256 | $11.46 | $3K | 8,287 |
| 2023-03-16 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | −872 | 1,744 | ||
| 2023-01-15 | Moat Ross CHIEF COMMERCIAL OFFICER | Grant or award | +1,844 | $9.56 | $18K | 10,008 |
| 2023-01-15 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award | +704 | $9.56 | $7K | 8,118 |
| 2022-11-29 | Quart Barry D Director | Option exercise | +21,959 | $1.59 | $35K | 21,959 |
| 2022-11-29 | Quart Barry D Director | Sale | −21,959 | $16.15 | $355K | 0 |
| 2022-11-29 | Quart Barry D Director | Option exercise · Share Option | −21,959 | 0 | ||
| 2022-11-07 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise | +28,357 | $1.86 | $53K | 64,692 |
| 2022-11-07 | Paolini John F. CHIEF MEDICAL OFFICER | Sale | −28,357 | $15.18 | $430K | 36,335 |
| 2022-11-07 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option | −28,357 | 169,217 |
Page 64 of 74 · 1,467 trades